Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Empiric Student Property Plc
-
Diana Shipping Inc. Announces Time Charter Contract for M/V P. S. Palios with Glencore
-
Cycurion, Inc. (NASDAQ: CYCU) Announces $500,000 Common Share Dividend to Be Paid to its Shareholders on or about December 30th
-
McMann Capital: Launches LOC to $750,000
-
DEFT Investors Have Opportunity to Lead DeFi Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
ProMach Acquires DFT Technology GmbH, a Leading Global Supplier for the Thermal Treatment of Food
-
Toro Corp. Declares Special Dividend of $1.75 Per Share
-
Entro Security Leads Shai Hulud 2.0 Response with Deep Secrets Analysis and Free Exposure Checker
-
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.16 per Share
-
Stansberry Asset Management Named to PSN Top Guns List of Best Performing Strategies for Q3 2025
-
Strategic Partnership with Leading UAE Family Office to Build a New Growth Engine in the Middle East and North Africa
-
Paribu has acquired CoinMENA, MENA’s largest local crypto exchange, in a transaction valued at up to USD 240 million
-
Allied Gaming and Entertainment Issues Statement to Shareholders and the Investment Community
-
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
-
Matthew Morningstar Joins LPL as Chief Legal Officer
-
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
-
Freight Technologies Announces Strategic Partnership with Solvento to Integrate Financial Workflows
-
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
-
Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 America
-
Accendatech US comments on the recent setback in phase 2 study to evaluate STAT3 as therapeutic target and other drug development strategies such as AI and precision medicine to treat patients with IP
-
STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
JYD Investors Have Opportunity to Lead Jayud Global Logistics Limited Securities Fraud Lawsuit with the Schall Law Firm
-
Edible Garden’s Pickle Party™ Line Starts to Ship at King Kullen, Expanding Access to Fresh, Fermented, Functional Kosher Pickles
-
Bitget Releases Major Upgrades to GetAgent With Smarter Responses and Free Access for All Users
-
Toro Corp. Reports Net Income of $1.3 Million for the Three Months Ended September 30, 2025 and $4.3 Million for the Nine Months Ended September 30, 2025
-
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm
-
MANAGERS' AND CLOSELY RELATED PARTIES' TRANSACTIONS WITH DFDS SHARES
-
CoinEx Completed 11th Monthly CET Repurchase and Burning of 2025
-
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Form 8.3 - Avadel Pharmaceuticals plc
-
Precious Metals & Critical Minerals Virtual Investor Conference: Presentations Now Available for Online Viewing
-
Precious Metals & Critical Minerals Virtual Investor Conference: Presentations Now Available for Online Viewing
-
Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th
-
Jeffs’ Brands Enters into a Definitive Agreement with Scanary, Marking Entry into the Global Homeland Security Market
-
Lead Real Estate Co., Ltd to Present at Sidoti's Year End Virtual Investor Conference on December 10-11, 2025
-
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
-
Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum
-
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
-
DeFi Crypto Mutuum Finance (MUTM) Reports Key Roadmap Phase 2 Milestones Passed Ahead of Q4 Launch
-
PRMB Investors Have Opportunity to Lead Primo Brands Corporation Securities Fraud Lawsuit with the Schall Law Firm
-
Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad
-
Motley Fool Wealth Management to Join Apollon Wealth Management
-
NetworkNewsAudio Announces Audio Press Release (APR) on Landmark Contribution Made by Natural Hydrogen Exploration, Development Leader
-
XT Exchange Rolls Out Soccer Prediction Cycle 2 With a $3,000,000 Reward Pool and 20% XScore Rebate
-
FCX Investors Have Opportunity to Lead Freeport-McMoRan Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Alpha Modus Signs Pilot With Major National Retailer to Deploy ~100 AlphaCash Kiosks, Opening Scalable Pathway Toward 1,000s Of Targeted Locations Nationwide
-
Echobit Lists ORIGYN/USDT Spot Trading Pair and Launches a 75,000 ORIGYN Platform-Wide Rewards Program
-
FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
New Crypto Mutuum Finance (MUTM) Nears $19.5M in Funding as V1 Q4 Timeline Remains on Track
